← Back to patent-cliff list
DT-678
Tier C — Watch / tradeDT-678
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：P2RY12
Indications (approved)：ST段抬高型心肌梗死, 非ST段抬高型心肌梗死, Ischaemic stroke, Acute coronary syndrome, Myocardial infarction, Unstable angina, Atherosclerosis, Thrombosis
Regional status
US
-
2024-11-01
EU
-
China
Phase II
2024-06-17
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of DT-678?
Approved indications include: ST段抬高型心肌梗死, 非ST段抬高型心肌梗死, Ischaemic stroke, Acute coronary syndrome, Myocardial infarction, Unstable angina, Atherosclerosis, Thrombosis.
When does the DT-678 patent expire?
No public expiry year is available for DT-678 yet; this page updates once verified.
How do I get a quote for DT-678 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01